Gynecologic Cancer News

The FDA granted fast track designation to ofranergene obadenovec in combination with paclitaxel for treatment of platinum-resistant ovarian cancer.

Break Through Cancer will award $50 million in grants designed to maximize interdisciplinary collaboration among researchers at five top cancer centers.

Early data from a phase 1 trial showed encouraging clinical activity for an investigational chimeric antigen receptor T-cell therapy alone or in combination with an amplifying mRNA vaccine for patients with solid tumors.

Arif Kamal, MD, MBA, MHS, chief patient officer at American Cancer Society, spoke with Healio about two national roundtables the society will launch to drive progress against breast cancer and cervical cancer.

Self-reported signs of distress and an increasing total Edmonton Symptom Assessment System score within 180 days of cancer diagnosis appeared associated with higher odds of nonfatal, self-inflicted injury, study results showed.

Rucaparib monotherapy significantly extended PFS compared with placebo as first-line maintenance treatment for women with ovarian cancer, according to topline data from the randomized phase 3 ATHENA-MONO trial.

A wait time of at least 20 days to undergo elective, low-risk, cancer-related surgery appeared safe following recovery from mild to moderate COVID-19, according to study results published in Annals of Surgical Oncology.

Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, according to randomized phase 3 trial results presented at Society of Gynecologic Oncology 2022 Annual Meeting on Women's Cancer.

Atezolizumab administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity among women with node-positive locally advanced cervical cancer, according to study results.

The University of Texas MD Anderson Cancer announced Thursday the launch of the James P. Allison Institute, a research and innovation hub that integrates immunobiology across disciplines to accelerate discoveries toward cancer cures.